---
figid: PMC7432778__ijms-21-05382-g006
figtitle: IL-17A has two receptor complexes, IL-17RA/IL-17RC and IL-17RA/IL-17RD,
  in keratinocytes
organisms:
- Saccharomyces cerevisiae
- Glycine max
- Inula helenium
- Opuntia ficus-indica
- Rhodiola crenulata
- Malassezia pachydermatis
- Artemisia princeps
- Mus musculus
- Rattus norvegicus
- Staphylococcus aureus
- Staphylococcus epidermidis
- Homo sapiens
pmcid: PMC7432778
filename: ijms-21-05382-g006.jpg
figlink: pmc/articles/PMC7432778/figure/ijms-21-05382-f006/
number: F6
caption: IL-17A has two receptor complexes, IL-17RA/IL-17RC and IL-17RA/IL-17RD, in
  keratinocytes. Signaling of both receptors occurs via downstream ACT1, TRAF6, and
  CARMA2 protein complexes, and activates nuclear factor kappa-light-chain-enhancer
  of activated B cells (NF-κB) and MAPKs. Activation of NF-κB and MAPKs induces cell
  proliferation and cyto/chemokine production in keratinocytes. IL-17A is not likely
  to directly activate JAK-STAT pathways. Another important transcription factor for
  IL-17A signaling is the C/CAAT-enhancer-binding protein β (C/EBPB) or C/EBPD. The
  IL-17A-C/EBPB pathway is likely to upregulate IVL expression, but to downregulate
  FLG and LOR expression.
papertitle: 'Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A,
  IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.'
reftext: Masutaka Furue. Int J Mol Sci. 2020 Aug;21(15):5382.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.90416
figid_alias: PMC7432778__F6
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC7432778__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7432778__ijms-21-05382-g006.html
  '@type': Dataset
  description: IL-17A has two receptor complexes, IL-17RA/IL-17RC and IL-17RA/IL-17RD,
    in keratinocytes. Signaling of both receptors occurs via downstream ACT1, TRAF6,
    and CARMA2 protein complexes, and activates nuclear factor kappa-light-chain-enhancer
    of activated B cells (NF-κB) and MAPKs. Activation of NF-κB and MAPKs induces
    cell proliferation and cyto/chemokine production in keratinocytes. IL-17A is not
    likely to directly activate JAK-STAT pathways. Another important transcription
    factor for IL-17A signaling is the C/CAAT-enhancer-binding protein β (C/EBPB)
    or C/EBPD. The IL-17A-C/EBPB pathway is likely to upregulate IVL expression, but
    to downregulate FLG and LOR expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il17a
  - Act1
  - Traf3ip2
  - Actvty1
  - Card14
  - Traf6
  - Cebpb
  - Nfkb1
  - Flg
  - Fgfr1
  - Ivl
  - Lor
  - Aass
  - Il17rd
  - Il17ra
  - Il17rc
  - Rela
  - Loricrin
  - IL17A
  - TRAF3IP2
  - CARD14
  - TRAF6
  - CEBPB
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - FLG
  - FGFR1
  - IVL
  - LORICRIN
  - LOXL2
  - IL17RD
  - IL17RA
  - IL17RC
---
